advertisement
11.5.2 Topical (10)
Showing records 1 to 10
Display all abstracts in classification 11.5.2 Topical
Search within classification 11.5.2 Topical6175 Comparison of the efficacy and safety of latanoprost 0.005% compared to brimonidine 0.2% or dorzolamide 2% when added to a topical beta-adrenergic blocker in patients with primary open-angle glaucoma or ocular hypertension
Stewart WC; Sharpe ED; Day DG; Kolker AE; Konstas AG; Lee WH; Rieser JC; Chopra H; Holmes KT
Journal of Ocular Pharmacology and Therapeutics 2000; 16: 251-259
6176 Brimonidine 0.2% versus dorzolamide 2% each given three times daily to reduce intraocular pressure
Stewart WC; Sharpe ED; Harbin TS Jr; Pastor SA; Day DG; Holmes KT; Stewart JA
American Journal of Ophthalmology 2000; 129: 723-727
6180 Effect of timolol, latanoprost, and dorzolamide on circadian IOP in glaucoma or ocular hypertension
Orzalesi N; Rossetti L; Invernizzi T; Bottoli A; Autelitano A
Investigative Ophthalmology and Visual Science 2000; 41: 2566-2573
6192 A comparison of latanoprost and dorzolamide in patients with glaucoma and ocular hypertension: a 3-month, randomised study
O'Donoghue EP; Austin M; Bates K; Birch M; Clearkin L; Condon P; James B; O'Brart D; Phelan P; Robinson R
British Journal of Ophthalmology 2000; 84: 579-582
6198 A topical or oral carbonic anhydrase inhibitor to control ocular hypertension after cataract surgery
Abbasoglu E; Tekeli O; Celikdogan A; Guersel E
European Journal of Ophthalmology 2000; 10: 27-31
6199 Carbonic anhydrase inhibitors: synthesis of topically effective intraocular pressure lowering agents derived from 5- (omega-aminoalkylcarboxamido)-1,3,4-thiadiazole-2-sulfonamide
Barboiu M; Supuran CT; Menabuoni L; Scozzafava A; Mincione F; Briganti F; Mincione G
Journal of Enzyme Inhibition 2000; 15: 23-46
6200 Carbonic anhydrase inhibitors: sulfonamides incorporating furan-, thiophene- and pyrrole-carboxamido groups possess strong topical intraocular pressure lowering properties as aqueous suspensions
Ilies M; Supuran CT; Scozzafava A; Casini A; Mincione F; Menabuoni L; Caproiu MT; Maganu M; Banciu MD
Bio-organic and Medicinal Chemistry 2000; 8: 2145-2155
6201 Formulation and evaluation of ophthalmic preparations of acetazolamide
Kaur IP; Singh M; Kanwar M
International Journal of Pharmaceutics 2000; 199: 119-127
6202 Pharmacological profiles of the potent carbonic anhydrase inhibitor dorzolamide hydrochloride, a topical antiglaucoma agent
Kobayashi M; Naito K
Nippon yakurigaku zasshi 2000; 115: 323-328
6203 Carbonic anhydrase inhibitors: topical sulfonamide antiglaucoma agents incorporating secondary amine moieties
Renzi G; Scozzafava A; Supuran CT
Bioorganic and Medicinal Chemistry Letters 2000; 10: 673-676